Ebola Virus Disease has Features of Hemophagocytic Lymphohistiocytosis Syndrome.
作者信息
van der Ven Andre J A M, Netea Mihai G, van der Meer Jos W M, de Mast Quirijn
机构信息
Department of Internal Medicine, Radboud University Medical Centre , Nijmegen , Netherlands.
出版信息
Front Med (Lausanne). 2015 Feb 4;2:4. doi: 10.3389/fmed.2015.00004. eCollection 2015.
Abstract
摘要
相似文献
1
Ebola Virus Disease has Features of Hemophagocytic Lymphohistiocytosis Syndrome.埃博拉病毒病具有噬血细胞性淋巴组织细胞增生综合征的特征。
Front Med (Lausanne). 2015 Feb 4;2:4. doi: 10.3389/fmed.2015.00004. eCollection 2015.
2
Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.阿那白滞素（一种白细胞介素-1受体拮抗剂）在危重症儿童继发性噬血细胞性淋巴组织细胞增生症/脓毒症/多器官功能障碍/巨噬细胞活化综合征治疗中的作用*
Pediatr Crit Care Med. 2014 Jun;15(5):401-8. doi: 10.1097/PCC.0000000000000078.
3
Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?巨噬细胞活化综合征与反应性噬血细胞性淋巴组织细胞增生症：是同一实体吗？
Curr Opin Rheumatol. 2003 Sep;15(5):587-90. doi: 10.1097/00002281-200309000-00011.
4
High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU.重症监护病房中继发性噬血细胞性淋巴组织细胞增生症/巨噬细胞活化综合征危重症患者的高容量血液滤过：一项前瞻性研究
Pediatr Crit Care Med. 2016 Oct;17(10):e437-e443. doi: 10.1097/PCC.0000000000000896.
5
Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans.人源巨噬细胞活化标志物可溶性 CD163 与致命性和重症埃博拉病毒病相关。
Emerg Infect Dis. 2019 Feb;25(2):290-298. doi: 10.3201/eid2502.181326.
6
Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis.噬血细胞性淋巴组织细胞增生症：诊断和发病机制的最新进展。
Am J Clin Pathol. 2013 Jun;139(6):713-27. doi: 10.1309/AJCP4ZDKJ4ICOUAT.
7
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome.巨噬细胞活化综合征/原发性噬血细胞性淋巴组织细胞增生症评分的开发与初步验证，一种区分原发性噬血细胞性淋巴组织细胞增生症与巨噬细胞活化综合征的诊断工具。
J Pediatr. 2017 Oct;189:72-78.e3. doi: 10.1016/j.jpeds.2017.06.005. Epub 2017 Aug 12.
8
Macrophage Activation Syndrome Versus Hemophagocytic Lymphohistiocytosis: A Diagnostic Dilemma in a Patient With Still's Disease and Epstein-Barr Virus Viremia.巨噬细胞活化综合征与噬血细胞性淋巴组织细胞增生症：1例斯蒂尔病合并爱泼斯坦-巴尔病毒血症患者的诊断困境
J Hematol. 2019 Jun;8(2):68-70. doi: 10.14740/jh495. Epub 2019 Jun 30.
9
[CME: Acquired Hemophagocytic Lymphohistiocytosis].[继续医学教育：获得性噬血细胞性淋巴组织细胞增生症]
Praxis (Bern 1994). 2018 Aug;107(16):873-881. doi: 10.1024/1661-8157/a003040.
10
Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis.确定铁蛋白在噬血细胞性淋巴组织细胞增生症诊断中的合适临界值。
Pediatr Blood Cancer. 2014 Nov;61(11):2101-3. doi: 10.1002/pbc.25058. Epub 2014 Apr 21.
引用本文的文献
1
Update in Hyperferritinemic Syndromes: Recognition and Management - A Scoping Review.高铁蛋白血症综合征的最新进展：识别与管理——一项范围综述
Brown J Hosp Med. 2022 Aug 19;1(3):37667. doi: 10.56305/001c.37667. eCollection 2022.
2
Hemophagocytic Lymphohistiocytosis Triggered by Herpes Simplex Virus 1 and 2: A Narrative Review.由单纯疱疹病毒1型和2型引发的噬血细胞性淋巴组织细胞增生症：一项叙述性综述
Hematol Rep. 2024 Jul 26;16(3):487-503. doi: 10.3390/hematolrep16030047.
3
Cytokine Storm Syndrome Associated with Hemorrhagic Fever and Other Viruses.细胞因子风暴综合征与出血热及其他病毒相关。
Adv Exp Med Biol. 2024;1448:249-267. doi: 10.1007/978-3-031-59815-9_17.
4
Macrophage Activation Syndrome in Viral Sepsis.病毒感染相关性噬血细胞综合征。
Viruses. 2024 Jun 22;16(7):1004. doi: 10.3390/v16071004.
5
Ebola Virus Disease Features Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in the Rhesus Macaque Model.埃博拉病毒病在恒河猴模型中具有噬血细胞性淋巴组织细胞增多症/巨噬细胞活化综合征的特征。
J Infect Dis. 2023 Aug 16;228(4):371-382. doi: 10.1093/infdis/jiad203.
6
Evaluation of Serum Ferritin, Procalcitonin, and C-Reactive Protein for the Prediction of Severity and Mortality in Hemorrhagic Fever With Renal Syndrome.评估血清铁蛋白、降钙素原和C反应蛋白对肾综合征出血热严重程度和死亡率的预测价值。
Front Microbiol. 2022 May 23;13:865233. doi: 10.3389/fmicb.2022.865233. eCollection 2022.
7
Potential therapeutic options for COVID-19: an update on current evidence.针对 COVID-19 的潜在治疗选择：当前证据的更新。
Eur J Med Res. 2022 Jan 13;27(1):6. doi: 10.1186/s40001-021-00626-3.
8
Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis.新冠病毒感染是否导致不同形式的继发性噬血细胞性淋巴组织细胞增生症？
Int J Mol Sci. 2021 Mar 15;22(6):2967. doi: 10.3390/ijms22062967.
9
Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus.临床警惕 EBV 所致噬血细胞综合征
Ital J Pediatr. 2021 Jan 7;47(1):3. doi: 10.1186/s13052-020-00949-7.
10
Treatment of Inflammatory Diseases with IL-1 Blockade.用白细胞介素-1阻断疗法治疗炎症性疾病。
Curr Otorhinolaryngol Rep. 2018;6(1):1-14. doi: 10.1007/s40136-018-0181-9. Epub 2018 Mar 7.
本文引用的文献
1
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.埃博拉病毒和马尔堡病毒的组织和细胞嗜性、病理学和发病机制。
J Pathol. 2015 Jan;235(2):153-74. doi: 10.1002/path.4456.
2
Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.阿那白滞素（一种白细胞介素-1受体拮抗剂）在危重症儿童继发性噬血细胞性淋巴组织细胞增生症/脓毒症/多器官功能障碍/巨噬细胞活化综合征治疗中的作用*
Pediatr Crit Care Med. 2014 Jun;15(5):401-8. doi: 10.1097/PCC.0000000000000078.
3
Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.埃博拉出血热：与临床结局相关的新型生物标志物。
J Infect Dis. 2014 Aug 15;210(4):558-66. doi: 10.1093/infdis/jiu088. Epub 2014 Feb 12.
4
Adult haemophagocytic syndrome.成人噬血细胞性淋巴组织细胞增生症。
Lancet. 2014 Apr 26;383(9927):1503-1516. doi: 10.1016/S0140-6736(13)61048-X. Epub 2013 Nov 27.
5
Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis.噬血细胞性淋巴组织细胞增生症：诊断和发病机制的最新进展。
Am J Clin Pathol. 2013 Jun;139(6):713-27. doi: 10.1309/AJCP4ZDKJ4ICOUAT.
6
Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells.穿孔素缺陷损害了涉及小鼠 CD8(+)T 细胞和树突状细胞的关键免疫调节回路。
Blood. 2013 Jun 27;121(26):5184-91. doi: 10.1182/blood-2013-04-495309. Epub 2013 May 9.
7
Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome.高剂量阿那白滞素在一例难治性巨噬细胞活化综合征中有效。
J Rheumatol. 2013 May;40(5):743-4. doi: 10.3899/jrheum.121098.
8
Successful immunotherapy in life-threatening parvovirus B19 infection in a child.儿童危及生命的细小病毒 B19 感染的成功免疫治疗。
Pediatr Infect Dis J. 2013 Jul;32(7):789-92. doi: 10.1097/INF.0b013e31828df4d1.
9
Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra.成功用阿那白滞素治疗成人斯蒂尔病合并巨噬细胞活化综合征。
Intern Med J. 2012 Dec;42(12):1358-62. doi: 10.1111/imj.12002.
10
Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.巨噬细胞活化综合征作为全身型幼年特发性关节炎的一部分：诊断、遗传学、病理生理学和治疗。
Genes Immun. 2012 Jun;13(4):289-98. doi: 10.1038/gene.2012.3. Epub 2012 Mar 15.
Zotero 插件